aBaylor College of Medicine, Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX
bSchool of Public Health, University of Washington, Seattle, WA
cBaylor College of Medicine, Houston, TX
dHarris Health System, Houston, TX
eCurrently Fred Hutchinson Cancer Research Center, Seattle WA
fCurrently Montefiore Medical Center, Bronx, NY
The HIV-related work was supported in part by the National Institute of Mental Health of the National Institutes of Health under Award Number K23MH094235 (Principal Investigator: Arya). This work was also supported in part by the Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413) of the Michael E. DeBakey Veterans Affairs Medical Center in Houston. The Harris Health RUSH program was supported by the Gilead HIV Focus Program, Texas Dept of State Health Services (2011-0351783, D-11-00102), and the CDC (PS07-768, PS10-10138, PS12-1201, PS07-768, PS10-1001, PS04-012).
Presented at National Summit on HCV and HIV Diagnosis, Prevention, and Access to Care; June 4-6, 2015; Arlington, VA.
The authors report no conflicts of interest.